Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Flavor shipments for beverages and other applications increased at the company and its Chinese subsidiary. Fragrance shipments increased at the Chinese subsidiary, while selling, general and administrative expenses, including amortization related to a new core operating system, increased at the French subsidiary. Aroma Ingredients was affected by higher raw material prices, while Fine Chemicals postponed shipments of overseas pharmaceutical intermediates to accommodate enhancements to the quality control system. By region, shipments decreased in the Americas, shipments were adjusted in Europe, and shipments increased in Asia, accompanied by optimization of raw materials.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥225,092 million (YoY -1.8%) |
| Operating profit | ¥8,132 million (YoY -47.0%) |
| Ordinary income | ¥9,511 million (YoY -37.9%) |
| Profit attributable to owners of the parent | ¥9,525 million (YoY -28.5%) |
| Net income per share | ¥97.72 |
| Operating Margin | 3.6% |
| Equity ratio | End of the current fiscal period 56.6% / End of previous period 55.0% |
| Total assets | ¥271,147 million |
| Net assets | ¥156,051 million |
| Cash flows from operating activities | ¥4,271 million |
| Cash flows from investing activities | ¥-16,222 million |
| Cash flows from financing activities | ¥-4,645 million |
| Cash and cash equivalents at end of period | ¥19,572 million |
| Full-year earnings forecast | Net Sales ¥240,000 million (YoY +6.6%) / Operating profit ¥11,000 million (YoY +35.3%) / Ordinary income ¥11,500 million (YoY +20.9%) / Net income ¥9,400 million (YoY -1.3%) |
| Annual Dividend Forecast | ¥260 (before taking the stock split into account) → ¥52 (after the split)（0.0% (after adjusting for the stock split)） |
| Payout ratio | Actual results for the current fiscal year 53.2% / Next-year forecast 53.9% |
| Segment revenue | Japan ¥76,968 million (YoY +4.6%), Americas ¥55,575 million (YoY -16.5%), Europe ¥42,395 million (YoY +7.8%), Asia ¥50,153 million (YoY +0.7%) |
| Segment profit | Japan ¥594 million (YoY -86.7%), Americas ¥908 million (YoY -64.8%), Europe ¥800 million (YoY -67.4%), Asia ¥5,650 million (YoY +14.2%) |
| Regional sales | ¥76,968 million (YoY +4.6%), ¥55,575 million (YoY -16.5%), ¥42,395 million (YoY +7.8%), ¥50,153 million (YoY +0.7%) |
| Depreciation and amortization | ¥8,756 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥17 million, Gain on sale of investment securities ¥4,426 million, Other ¥8 million / Extraordinary loss Losses on disposal of fixed assets ¥68 million, Provision for litigation loss ¥179 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 高砂香料（張家港）有限公司 / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 100,761,985 |
| Treasury Shares at Period-End | 3,265,935 |
| Factors Behind Changes in Business Performance | Flavor shipments for beverages and other applications increased at the company and its Chinese subsidiary. Fragrance shipments increased at the Chinese subsidiary, while selling, general and administrative expenses, including amortization related to a new core operating system, increased at the French subsidiary. Aroma Ingredients was affected by higher raw material prices, while Fine Chemicals postponed shipments of overseas pharmaceutical intermediates to accommodate enhancements to the quality control system. By region, shipments decreased in the Americas, shipments were adjusted in Europe, and shipments increased in Asia, accompanied by optimization of raw materials. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Fine Chemicals segment, shipments of overseas pharmaceutical intermediates were postponed to accommodate enhancements to the quality control system. In the Fragrance segment, selling, general and administrative expenses, including amortization related to a new core operating system at the French subsidiary, increased, while raw material prices rose in the Aroma Ingredients segment. For the next fiscal year, the company will seek to minimize the impact of higher raw material procurement costs and supply-side effects resulting from higher crude oil prices associated with the situation in the Middle East and logistics disruptions by reviewing selling prices and optimizing raw material procurement.